SCHEMBL22829135

SCHEMBL22829135

COc1cc(C(=O)NCc2cncc(-c3cccc(C(O)(C(=O)O)c4ccccc4)c3)n2)ccc1CNCC(O)c1ccc(O)c2[nH]c(=O)ccc12

nearest known ligand 0.55

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ ADRB2 P07550 19/20 0.55
▸ CHRM3 P20309 18/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22829133 1.00 ADRB2 (0.55) ADRB2CHRM3
SCHEMBL22829194 0.91 ADRB2 (0.57) ADRB2CHRM3
SCHEMBL22829192 0.91 ADRB2 (0.57) ADRB2CHRM3
SCHEMBL22829229 0.91 ADRB2 (0.57) ADRB2CHRM3
SCHEMBL22829232 0.91 ADRB2 (0.57) ADRB2CHRM3
SCHEMBL22829108 0.90 ADRB2 (0.57) ADRB2CHRM3
SCHEMBL22829111 0.90 ADRB2 (0.57) ADRB2CHRM3
SCHEMBL22829233 0.88 ADRB2 (0.59) ADRB2CHRM3
SCHEMBL22829230 0.88 ADRB2 (0.59) ADRB2CHRM3
SCHEMBL22829140 0.87 ADRB2 (0.65) ADRB2CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3484879-B1 HYDROXYQUINOLINONE COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY CHIESI FARM SPA (IT) 2020-12-30 — — EP claimed
EP-3484879-B1 HYDROXYQUINOLINONE COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY CHIESI FARM SPA (IT) 2020-12-30 — — EP disclosed
Send feedback